Quantcast Factors Affecting the First Stage (Sensitization) - Immunohematology and Blood Banking II

Share on Google+Share on FacebookShare on LinkedInShare on TwitterShare on DiggShare on Stumble Upon
Custom Search
 
  
 
b. Factors Affecting the First Stage (Sensitization). Red blood cell
sensitization with antibody obeys the law of mass action. Thus, the reaction between
antigen on the RBC surface and antibody is reversible and the quantity of
cell-bound antibody at equilibrium will vary depending on the reaction conditions and the
equilibrium constant of the antibody. The reaction conditions should be designed to
maximize the quantity of cell-bound antibody at equilibrium in order to facilitate
detection of either blood group antigen or antibody. Some of these reaction conditions
are described below:
(1)  Temperature. Most blood group antibodies show their greatest reactivity
over a restricted temperature range, some reacting optimally at 4C, others at 37C.
Antibodies reacting optimally at 37C have been described as "warm" antibodies, and
those reacting optimally at lower temperatures as "cold" antibodies. Agglutinins
(antibodies) having maximum reactivity at one temperature may have sufficient thermal
amplitude to be active at others. Antibody activity is usually tested at room temperature
and at 37C. Antibodies active at 37C are the most clinically significant, although "cold"
antibodies cannot be ignored if they have a wide thermal amplitude (for example, above
30C). Antibodies only reacting at lower temperatures may be of importance in patients
subjected to hypothermia.
(2)  pH. The pH optima for antibody reactivity in most blood-group systems
have not been investigated. For anti-RhO(D), the optimum pH lies between 6.5 and 7.
Antibodies of other blood-group specificities may have different pH optima (for example,
some examples of anti-M react best at pH 5.5).
(3)  Incubation time. Time is required for the antibody RBC reaction to reach
equilibrium. The amount of time required to reach this state will depend upon other
variables. The rate of antibody binding is greatest initially, so incubation times for
routine laboratory procedures may be relatively short (for example, 15 to 30 minutes).
Ionic strength.
(4)
(a) The ionic strength of the reaction medium is one of the
physiochemical conditions that play an important role in the binding of antibody to RBC
antigens. Ionic strength is a measure of intensity of the electrical field resulting from
ions in solution. Electro-static forces (interaction of positive and negative charges) play
an important role in antibody reaction involving RBCs. Red blood cells carry a large
electronegative charge, which serves to keep them from spontaneously aggregating.
This enables them to function efficiently in oxygen transport by maintaining a maximum
surface area available for gas diffusion. When RBCs are suspended in an electrolyte
solution (0.85 percent NaCl), the cations (positive) are attracted to the negatively
charged RBCs, and the RBC becomes surrounded by a diffuse double layer ("ionic
cloud"), that travels with the RBC as if it were part of it. The outer edge of this layer is
called the surface of shear or the
MD0846
1-13



Medical News
CKD, glomerulonephritis risk higher for those with psoriasis
(HealthDay)—Psoriasis is associated with a higher risk of developing chronic...
medicalxpress.com
Older women restrict driving more than older men
(HealthDay)—Older women restrict their driving activity more than older men,...
medicalxpress.com
Test predicts response to treatment for complication of leukemia stem cell treatment
A new test may reveal which patients will respond to...
medicalxpress.com
Thiazide prophylaxis for kidney stones doesn't increase DM risk
(HealthDay)—The risk of diabetes mellitus is not increased with thiazide...
medicalxpress.com
Wearable, doc-prescribed monitors may help spot high blood pressure
(HealthDay)—People suspected of having high blood pressure may soon be...
medicalxpress.com
Sublingual immunotherapy tablet safe in asthma patients
(HealthDay)—For individuals with asthma and allergic rhinitis with/without conjunctivitis (AR/C),...
medicalxpress.com
HbA1c below 7.6% cuts long-term vascular complications in T1DM
(HealthDay)—For patients with type 1 diabetes, long-term weighted mean hemoglobin...
medicalxpress.com
Inpatient admissions predict peri-op risk in lumbar fusion
(HealthDay)—For patients undergoing posterior lumbar fusion, inpatient admissions in the...
medicalxpress.com
Many states slow to update preparticipation physical exams
(HealthDay)—Many states have been slow to adopt preparticipation physical evaluation-fourth...
medicalxpress.com
Dermoscopically, melanoma, spitz nevi indistinguishable
(HealthDay)—Melanoma may be dermoscopically indistinguishable from Spitz nevi, according to...
medicalxpress.com
Rapivab approved to help treat flu
(HealthDay)—Rapivab (peramivir) has been approved by the U.S. Food and...
medicalxpress.com
Immune system may play role in obesity
(HealthDay)—Certain immune system cells may play an important role in...
medicalxpress.com
Patching up diabetic ulcers
Like the more than 29 million people in the U.S,...
scopeblog.stanford.edu
Weight training appears key to controlling belly fat
Healthy men who did twenty minutes of daily weight training...
medicalxpress.com
FDA approves new melanoma drug from Bristol-Myers
The Food and Drug Administration has approved a new drug...
medicalxpress.com
WHO gets green light to deliver medicine to Aleppo, other areas
Damascus has agreed to allow deliveries of desperately needed medical...
medicalxpress.com
Risk for leukemia after treatment for early-stage breast cancer higher than reported
The risk of developing leukemia after radiation therapy or chemotherapy...
medicalxpress.com
New concussion laws result in big jump in concussion treatment
New laws regulating concussion treatment, bolstered by heightened public awareness,...
medicalxpress.com
Using no-evidence-of-disease-activity standard for patients with multiple sclerosis
Maintaining "no-evidence-of-disease-activity" (NEDA) was difficult over time for many patients...
medicalxpress.com
CDC Director: Ebola Response Inspiring
(MedPage Today) -- But "sobering" challenges remain in West Africa....
medpagetoday.com
 


Privacy Statement - Copyright Information. - Contact Us

comments powered by Disqus

Integrated Publishing, Inc.
9438 US Hwy 19N #311 Port Richey, FL 34668

Phone For Parts Inquiries: (727) 755-3260
Google +